Association for Japan Health Food Certified
JHFC
← Back to Resources

Deep-Sea Fish Oil (EPA/DHA) · Labeling Standards and Cross-Border Compliance

Abstract

Deep-sea fish oil ranks among the world's best-selling dietary supplement categories. The accuracy of label declarations for its core constituents — EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid) — along with label compliance and cross-border regulatory conformance, have become central considerations for both consumer purchasing decisions and regulatory scrutiny. This paper systematically examines the principal regulatory frameworks and industry standards governing fish oil in Japan, the United States, the European Union, and China across three dimensions: ingredient quantity labeling requirements, label compliance elements, and cross-border purchasing considerations. It also distills actionable consumer verification pathways. No medical or efficacy claims are made herein.

---

I. EPA/DHA Quantity Labeling: An Overview of International Standards

1.1 The GOED Voluntary Standard: The Industry Baseline

The *GOED Omega-3 Monograph*, published by the Global Organization for EPA and DHA Omega-3s (GOED), is the most widely cited voluntary industry standard in the sector. Its key requirements include:

The GOED standard is voluntary in a legal sense, but in commercial practice it has been widely adopted by international buyers and certification bodies as a baseline market-entry requirement.

1.2 IFOS Certification: Third-Party Verification

The International Fish Oil Standards (IFOS) program, operated by Nutrasource in Canada, conducts independent, batch-level testing of fish oil products and publishes the results publicly. Achieving the five-star rating requires a product to simultaneously satisfy:

IFOS batch reports are a transparency tool directly accessible to consumers — an independent, third-party verification pathway entirely separate from brand self-reporting.

1.3 Codex Alimentarius: The International Food Standard for Fish Oils

The *CODEX STAN 329-2017* (Standard for Fish Oils), published by the FAO/WHO Codex Alimentarius Commission, establishes physicochemical specifications for fish oils intended for human consumption, including fatty acid composition ranges, iodine value, refractive index, and saponification value. This standard serves as a key reference for national regulatory frameworks and as technical background documentation for customs compliance purposes.

---

II. Japan Labeling Requirements: A Multi-Layered Regulatory Framework

2.1 Dual Constraints: The Food Labeling Act and the Health Promotion Act

Japan's labeling regime for health foods is anchored by the Food Labeling Act (2015), with supplementary advertising constraints under the Health Promotion Act. For fish oil products specifically, the following label elements are mandatory:

Under the general food framework, there is no mandatory obligation to disclose daily EPA/DHA intake or per-capsule content. However, once such information appears on a label, it becomes subject to the prohibition on false labeling, and any assay deviation must fall within an acceptable tolerance.

2.2 The Foods with Function Claims System: Strict Requirements for Ingredient Quantity Disclosure

Where a company elects to include function-related language referencing EPA/DHA on packaging — for example, specific phrases relating to neutral fat (*chūsei shibō*) — the product must be notified under the Foods with Function Claims (FFC) system (administered by the Consumer Affairs Agency, CAA). The notification filing must specify:

The CAA's public database discloses all notification records for accepted products. Consumers can retrieve the original notification documents by entering a product's notification number on the CAA website — this is the most practically accessible transparency verification tool available in the market.

2.3 JHNFA GMP Certification: A Verifiable Dimension of Manufacturing Quality

The GMP Conformity Certification (*GMP Tekigu Nintei*) issued by the Japan Health and Nutrition Food Association (JHNFA) is a third-party assessment of the quality management system at health food manufacturing facilities. It covers the full production workflow, including incoming raw material inspection, manufacturing process control, quality testing, and deviation management. Certification is granted at the facility level following an on-site audit, and the status of certified factories is publicly searchable on the JHNFA website.

As a concrete, verifiable example: a facility holding JHNFA GMP Conformity Certification (certification number 34225) has had its manufacturing quality management system formally assessed through the association's official review process. The searchability of the certification number itself constitutes an independent indicator of information transparency.

Importantly, GMP certification evaluates the factory's management system — it does not constitute endorsement of any individual product's ingredient content or efficacy. These are distinct regulatory dimensions.

---

III. United States Labeling Requirements: The DSHEA Supplement Facts Framework

3.1 Core Requirements Under the Dietary Supplement Health and Education Act (DSHEA)

In the United States, fish oil is classified as a dietary supplement and regulated under the Dietary Supplement Health and Education Act of 1994 (DSHEA). Specific labeling and manufacturing requirements are set out in FDA 21 CFR Parts 101 and 111:

The FDA's publicly available Dietary Supplement Ingredient Advisory List and recall database are official sources for verifying whether a specific brand has a documented history of labeling violations.

3.2 NSF International and USP Certification

The NSF International "NSF Contents Certified" mark requires products to pass independent laboratory testing confirming that measured ingredients match label declarations and that contaminant limits are met. The USP Verified Mark, issued by the United States Pharmacopeia, similarly applies verifiable standards for ingredient quantity accuracy, contaminants, and disintegration. Both marks are voluntary, but their certification databases are publicly searchable and constitute an accessible consumer verification pathway.

---

IV. European Union Labeling Requirements: Separating Nutrition Claims from Health Claims

4.1 Regulation (EC) No 1924/2006 on Nutrition and Health Claims

The EU's labeling constraints on fish oil products center on a fundamental distinction between two categories of claims:

This design — requiring health claims to be substantiated by scientific evidence and officially authorized — means that the EU maintains the most stringent ingredient quantity precision requirements of all major markets from a compliance standpoint. Once an authorized health claim is invoked, the product must be able to demonstrate that its content consistently meets the quantitative threshold associated with that claim.

4.2 Novel Food Regulation and Refined Fish Oil Sources

Certain DHA/EPA ingredients derived from microalgae — such as algal oil from *Schizochytrium* sp. — require authorization under the EU Novel Food Regulation (Regulation (EU) 2015/2283) before they may be placed on the market. Labels for such products must identify the approved source and applicable conditions of use. Consumers purchasing algae-based omega-3 products should verify authorization status through the EU Novel Food Catalogue.

---

V. Cross-Border Purchasing: Key Compliance Considerations

5.1 China Import Compliance: The Dual-Track System for Health Foods and General Foods

Under China's Administrative Measures for the Registration and Filing of Health Food (2016) and the Food Safety Law, imported health foods must hold a Blue Hat registration certificate or filing acknowledgment issued by the State Administration for Market Regulation (SAMR) before they may be sold in China as health food products. For fish oil products marketed as health food in China:

Personal importation of fish oil products into China for individual use — provided quantities fall within the reasonable personal-use threshold as defined by the General Administration of Customs — is generally handled as personal-use goods. Commercial distribution requires adherence to the health food import compliance pathway.

5.2 Label Language and Dual Ingredient Verification

When purchasing or Western fish oil products across borders, consumers should be aware of the following:

5.3 Oxidation Status and Transport Conditions

Fish oil oxidation is significantly accelerated by heat, light, and oxygen exposure. Given the extended transit times involved in cross-border shipping, consumers may perform a preliminary assessment upon receipt using the following observable indicators:

5.4 Species Sourcing and Sustainability Certification Transparency

Verifiable raw material sourcing information consumers can check includes:

---

VI. Consumer Verification Checklist

---

Closing Remarks

The labeling regulatory framework for EPA/DHA fish oil products is relatively well developed across the major markets of Japan, the United States, and the European Union. Nevertheless, significant differences remain across jurisdictions with respect to the precision required for ingredient quantity declarations, the scope of permissible health claim language, and the mutual recognition of third-party certifications.

For consumers making cross-border purchases, the most effective approach to moving beyond brand narratives and grounding decisions in verifiable facts is to verify the consistency between stated and measured ingredient quantities, review publicly available oxidation test data, confirm the GMP certification status of the manufacturing facility, and check the searchability of the product's notification or registration record.

Dietary supplements are not medicines under any established regulatory framework. All labeling standards and certification requirements discussed in this paper pertain exclusively to verifiable dimensions of raw material quality, ingredient content, and information transparency. Nothing herein constitutes medical advice. Consumers with health management needs should consult a licensed healthcare professional.

This document concerns quality/transparency only and makes no claim of pharmaceutical efficacy or disease treatment/prevention.
← Back to Resources